Literature DB >> 25517952

Is carcinoma in columnar-lined esophagus always located adjacent to intestinal metaplasia?: a histopathologic assessment.

Junko Aida1, Michael Vieth, Neil A Shepherd, Christian Ell, Andrea May, Horst Neuhaus, Tatsuro Ishizaki, Makoto Nishimura, Mutsunori Fujiwara, Tomio Arai, Kaiyo Takubo.   

Abstract

Diagnostic criteria for Barrett esophagus in the United States and elsewhere, except the United Kingdom and Japan, include the presence of intestinal metaplasia with goblet cells. We analyzed high-grade dysplasia and adenocarcinoma in a complete series of sections of all interfaces between carcinoma in columnar-lined esophagus (CLE) and the adjacent mucosa, assessed them for the mucosal types present, and calculated the proportion of each mucosal type in each case. The materials were a consecutive series of 100 endoscopic resection cases, comprising a total of 1251 microscopic sections. After excluding cases in which intestinal-type or cardiac-type mucosa was not adjacent to CLE carcinoma, 70 cases remained, for which 885 sections were available. Whether the adjacent mucosa was primarily cardiac or intestinal in type was assessed, as were the patterns of immunostaining for HGM, MUC-2, and MUC-6. Twenty-four (34.3%) of the 70 CLE carcinomas were completely surrounded by cardiac-type mucosa, and 10 (14.3%) were completely surrounded by intestinal-type mucosa. In 13 (18.6%), the entire non-neoplastic mucosa of the endoscopic resection specimen comprised the cardiac type alone without any intestinal type, and only 3 (4.3%) comprised the intestinal type only, without any cardiac type. From these findings, we consider it unproven histogenetically that the background mucosa of CLE carcinoma is predominantly of the intestinal type. CLE carcinoma was not demonstrated to have a close relationship with CLE mucosa with intestinal metaplasia.

Entities:  

Mesh:

Year:  2015        PMID: 25517952     DOI: 10.1097/PAS.0000000000000350

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  11 in total

Review 1.  Diagnosis and Surveillance of Barrett's Esophagus: Addressing the Transatlantic Divide.

Authors:  Saad Ghaus; Helmut Neumann; Humayun Muhammad; Gian Eugenio Tontini; Sauid Ishaq
Journal:  Dig Dis Sci       Date:  2016-04-01       Impact factor: 3.199

2.  Early Barrett esophagus-related neoplasia in segments 1 cm or longer is always associated with intestinal metaplasia.

Authors:  Benjamin Michael Allanson; Jessica Bonavita; Bob Mirzai; Tze Sheng Khor; Spiro C Raftopoulos; Willem Bastiaan de Boer; Ian S Brown; Marian Priyanthi Kumarasinghe
Journal:  Mod Pathol       Date:  2017-05-26       Impact factor: 7.842

3.  Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction.

Authors:  Kentaro Sugano; Stuart Jon Spechler; Emad M El-Omar; Kenneth E L McColl; Kaiyo Takubo; Takuji Gotoda; Mitsuhiro Fujishiro; Katsunori Iijima; Haruhiro Inoue; Takashi Kawai; Yoshikazu Kinoshita; Hiroto Miwa; Ken-Ichi Mukaisho; Kazunari Murakami; Yasuyuki Seto; Hisao Tajiri; Shobna Bhatia; Myung-Gyu Choi; Rebecca C Fitzgerald; Kwong Ming Fock; Khean-Lee Goh; Khek Yu Ho; Varocha Mahachai; Maria O'Donovan; Robert Odze; Richard Peek; Massimo Rugge; Prateek Sharma; Jose D Sollano; Michael Vieth; Justin Wu; Ming-Shiang Wu; Duowu Zou; Michio Kaminishi; Peter Malfertheiner
Journal:  Gut       Date:  2022-06-20       Impact factor: 31.793

4.  Neoplastic Barrett's oesophagus and long-term follow-up after endoscopic therapy: complete histological eradication of Barrett associated with high-grade dysplasia significantly decreases neoplasia relapse.

Authors:  Fabrice Caillol; Sebastien Godat; Aurelie Autret; Erwan Bories; Christian Pesenti; Jean Phillippe Ratone; Flora Poizat; Jerome Guiramand; Jean Robert Delpero; Marc Giovannini
Journal:  Surg Endosc       Date:  2016-04-29       Impact factor: 4.584

Review 5.  Histology of Barrett's Metaplasia: Do Goblet Cells Matter?

Authors:  Robert Odze
Journal:  Dig Dis Sci       Date:  2018-08       Impact factor: 3.199

6.  Loss of SRY-box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma.

Authors:  F J C Ten Kate; S H van Olphen; M J Bruno; B P L Wijnhoven; J J B van Lanschot; L H J Looijenga; R C Fitzgerald; K Biermann
Journal:  Br J Surg       Date:  2017-07-10       Impact factor: 6.939

Review 7.  The metaplastic mosaic of Barrett's oesophagus.

Authors:  Sujata Biswas; Michael Quante; Simon Leedham; Marnix Jansen
Journal:  Virchows Arch       Date:  2018-03-03       Impact factor: 4.064

8.  Barretts's carcinogenesis.

Authors:  Ken-Ichi Mukaisho; Shunpei Kanai; Ryoji Kushima; Takahisa Nakayama; Takanori Hattori; Hiroyuki Sugihara
Journal:  Pathol Int       Date:  2019-07-10       Impact factor: 2.534

Review 9.  Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance.

Authors:  Michael B Cook; Aaron P Thrift
Journal:  Gastrointest Endosc Clin N Am       Date:  2020-10-21

10.  Evolution of oesophageal adenocarcinoma from metaplastic columnar epithelium without goblet cells in Barrett's oesophagus.

Authors:  Danielle L Lavery; Pierre Martinez; Laura J Gay; Biancastella Cereser; Marco R Novelli; Manuel Rodriguez-Justo; Sybren L Meijer; Trevor A Graham; Stuart A C McDonald; Nicholas A Wright; Marnix Jansen
Journal:  Gut       Date:  2015-12-23       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.